Cargando…

The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia

A field study was undertaken to (i) measure the prevalence of feline leukaemia virus (FeLV) exposure and FeLV infection in a cross-section of healthy Australian pet cats; and (ii) investigate the outcomes following natural FeLV exposure in two Australian rescue facilities. Group 1 (n = 440) consiste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westman, Mark, Norris, Jacqueline, Malik, Richard, Hofmann-Lehmann, Regina, Harvey, Andrea, McLuckie, Alicia, Perkins, Martine, Schofield, Donna, Marcus, Alan, McDonald, Mike, Ward, Michael, Hall, Evelyn, Sheehy, Paul, Hosie, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630418/ https://www.ncbi.nlm.nih.gov/pubmed/31159230 http://dx.doi.org/10.3390/v11060503

Ejemplares similares

Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax(®) Lv-K and Fel-O-Vax(®) 5)
por: Westman, Mark, et al.
Publicado: (2021)

Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus
por: Almeras, T., et al.
Publicado: (2017)

Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats
por: Reinacher, M.
Publicado: (1989)

Could Phylogenetic Analysis Be Used for Feline Leukemia Virus (FeLV) Classification?
por: Cano-Ortiz, Lucía, et al.
Publicado: (2022)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Development of antibodies to feline IFN-γ as tools to elucidate the cellular immune responses to FeLV
por: Graham, Elizabeth M., et al.
Publicado: (2003)

Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection
por: Major, Andrea, et al.
Publicado: (2009)

Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection
por: Hofmann-Lehmann, R., et al.
Publicado: (1995)

Complete Genome Sequence of Feline Leukemia Virus Kawakami-Theilen Strain KT-FeLV-UCD-1
por: Chin, Pei-Ju, et al.
Publicado: (2020)

Acute monoblastic leukemia in a FeLV-positive cat
por: Prihirunkit, Kreangsak, et al.
Publicado: (2008)

Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR
por: Finstad, Samantha L, et al.
Publicado: (2004)

Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias
por: Abdollahi-Pirbazari, Mehdi, et al.
Publicado: (2019)

Molecular characterization of Brazilian FeLV strains in São Luis, Maranhão Brazil
por: Martins, Nathálya dos Santos, et al.
Publicado: (2023)

Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
por: Brunner, Chantal, et al.
Publicado: (2006)

Viral Determinants of FeLV Infection and Pathogenesis: Lessons Learned from Analysis of a Natural Cohort
por: Bolin, Lisa L., et al.
Publicado: (2011)

High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings
por: Suntz, M., et al.
Publicado: (2010)

Segregation of RD-114 and FeLV-related sequences in crosses between domestic cat and leopard cat
por: BENVENISTE, RAOUL E., et al.
Publicado: (1975)

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
por: Ortiz, Raquel, et al.
Publicado: (2023)

Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008–2019)
por: Pare, Amelie, et al.
Publicado: (2022)

Seroprevalence of feline immunodeficiency virus and feline leukaemia virus in Australia: risk factors for infection and geographical influences (2011–2013)
por: Westman, Mark E, et al.
Publicado: (2016)

Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection
por: Wilson, Stephen, et al.
Publicado: (2012)

Novel approach of dermatophytosis eradication in shelters: effect of Pythium oligandrum on Microsporum canis in FIV or FeLV positive cats
por: Načeradská, Martina, et al.
Publicado: (2021)

Epidemiology and clinical outcomes of feline immunodeficiency virus and feline leukaemia virus in client-owned cats in New Zealand
por: Luckman, Claire, et al.
Publicado: (2017)

Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha
por: Gomez-Lucia, Esperanza, et al.
Publicado: (2019)

Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus
por: Parr, Yasmin A., et al.
Publicado: (2021)

Feline leukaemia. ABCD guidelines on prevention and management
por: Lutz, Hans, et al.
Publicado: (2009)

First description of a multisystemic and lethal SARS-CoV-2 variant of concern P.1 (Gamma) infection in a FeLV-positive cat
por: Carneiro, Rodrigo Lima, et al.
Publicado: (2022)

Antiviral effect of mefloquine on feline calicivirus in vitro
por: McDonagh, Phillip, et al.
Publicado: (2015)

Felis Catus Gammaherpesvirus 1 DNAemia in Whole Blood from Therapeutically Immunosuppressed or Retrovirus-Infected Cats
por: McLuckie, Alicia J., et al.
Publicado: (2017)

Identification and characterisation of small molecule inhibitors of feline coronavirus replication
por: McDonagh, Phillip, et al.
Publicado: (2014)

In vitro inhibition of feline coronavirus replication by small interfering RNAs
por: McDonagh, Phillip, et al.
Publicado: (2011)

Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus
por: Stewart, Hazel, et al.
Publicado: (2012)

Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study
por: Spiri, Andrea M., et al.
Publicado: (2021)

Prevalence of Different Courses of Feline Leukaemia Virus Infection in Four European Countries
por: Giselbrecht, Juliana, et al.
Publicado: (2023)

Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro
por: McDonagh, Phillip, et al.
Publicado: (2015)

Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax(®) FIV)
por: Westman, Mark, et al.
Publicado: (2021)

Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge
por: Spiri, Andrea M., et al.
Publicado: (2021)

Prevalence of feline immunodeficiency virus and feline leukaemia virus in domestic cats in Hungary
por: Szilasi, Anna, et al.
Publicado: (2019)

Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility
por: Spiri, Andrea Monika, et al.
Publicado: (2019)

Prevalence and risk factors of feline leukaemia virus and feline immunodeficiency virus in peninsular Malaysia
por: Bande, Faruku, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qr6qmi05itlu11b1rpcod8c1dh